# clm_C75019B7A8F6

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: total_equity  
value: 20,997,000,000 United States dollar  
valid_from: 2023-03-31  
valid_to: 2023-06-30  
published: 2023-05-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_7D955D2EB31A  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences total equity: 20,997,000,000 United States dollar", as of 2023-03-31 (until 2023-06-30). Claim clm_C75019B7A8F6, https://asof.is/claim/clm_C75019B7A8F6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209523000017/0000882095-23-000017-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q1 FY2023, filed 2023-05-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209523000017/0000882095-23-000017-index.htm (primary, SEC EDGAR 10-Q Q1 FY2023, published 2023-05-03)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | total_equity | 21,240,000,000 United States dollar | valid 2022-12-31 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_C75019B7A8F6](/claim/clm_C75019B7A8F6.md) | [clm_9F042AE98A38](/claim/clm_9F042AE98A38.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.